WAVE Life Sciences (NASDAQ: WVE) reported Q1 EPS of ($0.13), $0.19 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $38.25 million versus the consensus estimate of $8.34 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.